Tenderwize
Retour à la recherche

Open House Discount Contracts for Amifampridin (ATC N07XX05)

AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse·Eisenberg, Germany·Deadline Feb 28, 2027 · 132 days left·Open·Supplies
Structured notice only
Titre original de l'avis

Germany – Pharmaceutical products – Open house Arzneimittelrabattverträge zum Wirkstoff Amifampridin, ATC N07XX05

50/100

Score d'opportunité

Needs reviewLow complexity
SuppliesOpen
Pourquoi ce score ?

Opportunité

50 / 100

Complexité

20 / 100

Facteurs de risque

The buyer reserves the right to replace open-house contracts with exclusive contracts at any time, leading to automatic...

No minimum volume or revenue guarantee; contracts are discount agreements only.

Analyse approfondie du portefeuille

Analyse approfondie de l'adéquation entreprise

Utilise:

  • Description
  • Industries & Services
  • Capabilities
  • Market & Experience
  • Certifications

Informations clés

Pouvoir adjudicateur
AOK Rheinland-Pfalz/Saarland - Die Gesundheitskasse
Pays
Allemagne
CPV
33600000 - Pharmaceutical products
Date limite
Feb 28, 2027

Aperçu

Moderate opportunity

Faits clés

  • Supplies contract
  • 1 lot
  • Duration until Apr 2027
  • Non-exclusive discount contracts for Amifampridin (ATC N07XX05) to be supplied to the AOK Rheinland-Pfalz/Saarland.
  • Standardized contract terms; no negotiations.
Afficher le résumé complet

This is a non-exclusive open-house procedure for pharmaceutical discount contracts for the active ingredient Amifampridin (ATC N07XX05), organized by AOK Rheinland-Pfalz/Saarland. The procedure allows any interested pharmaceutical company to enter into standardized discount agreements without competitive selection. Contracts run up to 24 months from the earliest start date (01.05.2025) and can be terminated automatically if the buyer awards exclusive contracts. The notice is published voluntarily for transparency and is not subject to EU procurement law despite using the standard form.

Risques

The buyer reserves the right to replace open-house contracts with exclusive contracts at any time, leading to automatic...

No minimum volume or revenue guarantee; contracts are discount agreements only.

L'analyse peut être incomplète

Seule une partie des documents de consultation a été analysée. Des exigences, certificats ou documents de soumission supplémentaires peuvent exister dans les documents restants.

Exigences clés

Technical

  • Pharmaceutical companies must be authorized to market Amifampridin in Germany.
  • Drugs must be approved and marketable in Germany, proven by Lauer-Taxe listing or AMIce database extracts.

Administrative

  • Physical submission of signed contract documents; electronic submission not allowed.

Les exigences peuvent être incomplètes.

Acheteur

Localisation

Eisenberg, DEU

Profil acheteur

Ouvrir le profil

Identifiant

DE271900642

Activité

Health

Lots (1)

LOT-0001

Open House Discount Contracts for Amifampridin (ATC N07XX05)

Non-exclusive discount contracts for Amifampridin with standardized terms. No negotiations, no exclusivity. Contracts end at the latest 24 months after the first contract start (01.05.2025), regardless of individual start dates. The buyer may replace these contracts with exclusive contracts at any time, causing automatic termination.

SuppliesEU fundedElectronic submission

Localisation

Eisenberg, Germany

Durée

Apr 2025 - Apr 2027

Catégorie

Pharmaceutical products

Date limite

Deadline Feb 28, 2027

Détails de la procédure

Date de publication
12 Mar 2025
Langues
German

Métadonnées de référence

Base juridique
32014L0024

Identifiants de référence

ID de l'appel d'offres
164018-2025

Documents (1)

Appels d'offres similaires